Eurobio Scientific Société anonyme (FRA:E8TN)

Market Cap	199.35M -22.2%
Revenue (ttm)	168.60M +9.1%
Net Income	4.87M +21.7%
EPS	0.47 +20.5%
Shares Out	n/a
PE Ratio	40.98
Forward PE	17.19
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	19.60
Previous Close	20.30
Day's Range	19.60 - 19.60
52-Week Range	19.60 - 25.75
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 24, 2026

About FRA:E8TN

Eurobio Scientific Société anonyme engages in research, development, and marketing specialty diagnostic products in the areas of transplantation, infectious diseases, autoimmunity, oncology, and life sciences. The company produces and markets transport and preservation media for corneal grafts; AlloMap, for heart transplant follow up; cell culture media, molecular biology reagents, contract manufacturing service, and proprietary antibodies; TQS (Tetanus Quick Stick), a rapid test used in emergency departments or pharmacies to assess the vaccina...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1997
• Employees: 343
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: E8TN

Financial Performance

In 2025, FRA:E8TN's revenue was 168.60 million, an increase of 9.08% compared to the previous year's 154.56 million. Earnings were 4.87 million, an increase of 21.69%.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 26, 2026

Data Sources Report a data error